[Consensus for the study and treatment of Fabry disease. GETER Foundation]

MeSH terms

• Adolescent
• Adult
• Cardiovascular Agents / therapeutic use
• Child
• Contraindications
• Delayed Diagnosis
• Diagnosis, Differential
• Disease Management
• Enzyme Replacement Therapy
• Fabry Disease / diagnosis
• Fabry Disease / drug therapy
• Fabry Disease / epidemiology
• Fabry Disease / genetics
• Fabry Disease / therapy*
• Female
• Heart Diseases / diagnosis
• Heart Diseases / drug therapy
• Heart Diseases / etiology
• Humans
• Incidence
• Infant, Newborn
• Kidney Failure, Chronic / diagnosis
• Kidney Failure, Chronic / etiology
• Kidney Failure, Chronic / therapy
• Leukocytes / enzymology
• Lysosomes / enzymology
• Male
• Neuralgia / drug therapy
• Neuralgia / etiology
• Renal Replacement Therapy
• alpha-Galactosidase / blood
• alpha-Galactosidase / genetics
• alpha-Galactosidase / therapeutic use